Alcohol Septal Ablation in Patients with Hypertrophic Cardiomyopathy and Obesity

Alcohol Septal Ablation in Patients with Hypertrophic Cardiomyopathy and Obesity

The article represents a literature review and analysis of actual experience of the treatment of patients with hypertrophic cardiomyopathy (HCM) and obesity. Obesity is a significant risk factor for the development and course of cardiovascular diseases. There are a lot of articles describing the “ob...

Full description

Bibliographic Details
Main Authors:	K. V. Rudenko, L. O. Nevmerzhytska, O. Yu. Dudnyk, S. M. Fanta, V. I. Malaniuk, V. V. Lazoryshynets
Format:	Article
Language:	English
Published:	Professional Edition Eastern Europe 2019-05-01
Series:	Український журнал серцево-судинної хірургії
Subjects:	hypertrophic cardiomyopathy obesity obesity paradox alcohol septal ablation
Online Access:	http://cvs.org.ua/index.php/ujcvs/article/view/116

Similar Items

Results of the alcohol septal ablation in combination with simultaneous endoprosthesis of coronary arteries in treatment of patients, suffering obstructive hypertrophic cardiomyopathy and concurrent ischemic heart disease
by: K. V. Rudenko, et al.
Published: (2019-12-01)

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: focus on safety
by: J Veselka
Published: (2007-12-01)

Surgical septal myectomy versus septal alcohol ablation for hypertrophic obstructive cardiomyopathy: a continuing debate
by: S Meditskou, et al.
Published: (2008-05-01)

Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
by: Victor Arévalos, et al.
Published: (2021-05-01)

The results of alcohol septal ablation in patients with hypertrophic cardiomiopathy and arterial hypertension
by: K. V. Rudenko, et al.
Published: (2020-02-01)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
by: Felice Gragnano, et al.
Published: (2023-04-01)

The results of alcoholic septal ablation in the treatment of hypertrophic cardiomyopathy
by: B.M. Todurov, et al.
Published: (2020-12-01)

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy
by: Tolga Aksu, et al.
Published: (2017-01-01)

Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
by: Ibadete Bytyçi, et al.
Published: (2020-09-01)

Morphological Changes on the Interventricular Septal Myocardium within the First Hours after Alcohol Septal Ablation in Patients with Hypertrophic Cardiomyopathy
by: V. P. Zakharova, et al.
Published: (2019-03-01)

How Symptomatic Should a Hypertrophic Obstructive Cardiomyopathy Patient Be to Consider Alcohol Septal Ablation?
by: Brandon M. Jones, et al.
Published: (2017-05-01)

A Case Report of Percutaneous Transluminal Septal Myocardial Ablation in Patients with Hypertrophic Cardiomyopathy
by: Mohammad Hasan Namazi, et al.
Published: (2004-12-01)

Conduction abnormalities post alcohol septal ablation for hypertrophic cardiomyopathy – A single center experience
by: Avinash Mani, et al.
Published: (2021-11-01)

Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy- Is Myocardial Contrast Echocardiography Mandatory?
by: Sridhar Lakshmana Sastry, et al.
Published: (2022-01-01)

Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
by: Alexandru Achim, et al.
Published: (2023-06-01)

Percutaneous transluminal septal alcoholization for the treatment of refractory hypertrophic obstructive cardiomyopathy: initial experience in the Federal District
by: Evandro César Vidal Osterne, et al.
Published: (2003-04-01)

Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
by: Xifeng Zheng, et al.
Published: (2022-05-01)

Short- and Mid-Term Outcomes of Early Alcohol Septal Ablation Therapy for Patients with Mildly Symptomatic Hypertrophic Obstructive Cardiomyopathy: A Tertiary Center Experience
by: Veysel Oktay, et al.
Published: (2024-03-01)

Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
by: Smita Scholtz, et al.
Published: (2023-10-01)

Surgical Myectomy after Failed Ablation for Hypertrophic Obstructive Cardiomyopathy
by: Ioannis Bougioukas, et al.
Published: (2016-04-01)

Sex-related differences in left ventricular remodeling and outcome after alcohol septal ablation in hypertrophic obstructive cardiomyopathy: insights from cardiovascular magnetic resonance imaging
by: You-Zhou Chen, et al.
Published: (2022-07-01)

The Risk of Ventricular Arrhythmias between Alcohol Septal Ablation and Septal Myectomy in Hypertrophic Cardiomyopathy: A Meta-Analysis on Septal Reduction Therapy
by: Wei Tang, et al.
Published: (2022-11-01)

Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy?
by: Elnur Alizade, et al.
Published: (2018-05-01)

Periprocedural, Short-Term, and Long-Term Outcomes of Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A 20-Year Single-Center Experience
by: Umut Karabulut, et al.
Published: (2022-12-01)

Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy
by: Ahmed M. Altibi, et al.
Published: (2023-05-01)

Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy: Volume Still Matters for Septal Myectomy
by: Vincent Y. See, et al.
Published: (2023-05-01)

Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
by: Xiangbin Meng, et al.
Published: (2022-03-01)

Is alcohol ablation of the septum associated with recurrent tachyarrhythmias?
by: O Hess
Published: (2007-12-01)

Hypertrophic obstructive cardiomyopathy with left ventricle outflow tract chordae insertion: Surgery or alcohol septal ablation? A case report
by: Rania Hammami, et al.
Published: (2023-09-01)

Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy
by: Hong-Chang Guo, et al.
Published: (2018-01-01)

Alcohol Septal Ablation of Hyperthropic Obstructive Cardiomyopathy Patient with Respiratory Failure
by: Jusuf Endang, et al.
Published: (2013-10-01)

Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis
by: Camila Cássia Canzi, et al.
Published: (2022-12-01)

Early onset obstructive hypertrophic cardiomyopathy in a physi-cally active male treated with alcohol septal ablation
by: Lea Cofek, et al.
Published: (2023-01-01)

Hemodynamic change in patients with hypertrophic obstructive cardiomyopathy before and after alcohol septal ablation using 4D flow magnetic resonance imaging: a retrospective observational study
by: Kenichiro Suwa, et al.
Published: (2021-04-01)

Vector electrocardiographic alterations after percutaneous septal ablation in obstructive hypertrophic cardiomyopathy: possible anatomic causes
by: Pérez Riera Andrés Ricardo, et al.
Published: (2002-01-01)

Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long‐Term Follow‐Up Study Based on the Euro‐Alcohol Septal Ablation Registry
by: Josef Veselka, et al.
Published: (2017-05-01)

Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience
by: Christian Steinberg, et al.
Published: (2020-10-01)

Inter-ventricular Septum Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy
by: Yuejin Wu, MS, Shaobo Duan, MD, Luwen Liu, MS, Shuaiyang Wang, MS, Shuang Xu, MS, Liuwei Hao, BS, Lianzhong Zhang, MD
Published: (2020-12-01)

Decreasing amplitude of left ventricular outflow tract gradient and its influencing factors after alcohol septal ablation
by: ZHANG Yong, et al.
Published: (2020-03-01)

Preoperative myocardial fibrosis is associated with worse survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: A delayed enhanced cardiac magnetic resonance study
by: Youzhou Chen, et al.
Published: (2022-08-01)